Q3 2023 Holdings
Filed 2023-11-14 | 2362 holdings | $39.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I | COM | 74006W108 | $26.8K | 15,700 | 0.0% |
| Hycroft Mining Holding Corp(HYMCUSD) | COM CL A | 44862P109 | $29.3K | 98,100 | 0.0% |
| Neonode Inc(NEON) | COM PAR | 64051M709 | $29.3K | 18,300 | 0.0% |
| Oncternal Therapeutics Inc | COM | 68236P107 | $29.5K | 98,400 | 0.0% |
| Aquabounty Technologies Inc(ABTUGBX) | COM NEW | 03842K200 | $30.2K | 126,357 | 0.0% |
| Charles & Colvard LTD(CTHRUSD) | COM | 159765106 | $30.7K | 53,700 | 0.0% |
| Fluent Inc(IDIEUR) | COM | 34380C102 | $30.9K | 69,500 | 0.0% |
| Lloyds Banking Group PLC(LYG) | SPONSORED ADR | 539439109 | $31.3K | 14,700 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS NEW | M47238122 | $31.4K | 50,633 | 0.0% |
| Franklin STR Pptys Corp(FSP) | COM | 35471R106 | $32.0K | 17,300 | 0.0% |
| Quantum SI Inc(QSI) | COM CL A | 74765K105 | $32.2K | 19,400 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $32.8K | 12,200 | 0.0% |
| Lilium N V | CLASS A ORD SHS | N52586109 | $34.6K | 48,500 | 0.0% |
| Barnes & Noble ED Inc(BNEDUSD) | COM | 06777U101 | $35.4K | 32,500 | 0.0% |
| ESS Tech Inc | COMMON STOCK | 26916J106 | $35.7K | 19,000 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $38.0K | 34,844 | 0.0% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $38.8K | 15,600 | 0.0% |
| Blend Labs Inc(BLND) | CL A | 09352U108 | $38.9K | 28,400 | 0.0% |
| Suro Capital Corp(SSSS) | COM NEW | 86887Q109 | $39.3K | 10,848 | 0.0% |
| Acacia Resh Corp(ACTG) | ACACIA TCH COM | 003881307 | $39.4K | 10,800 | 0.0% |
| GSI Technology Inc(GSIT) | COM | 36241U106 | $39.6K | 14,600 | 0.0% |
| Advantage Solutions Inc(ADV) | COM CL A | 00791N102 | $40.9K | 14,400 | 0.0% |
| Rent the Runway Inc | COM CL A | 76010Y103 | $42.3K | 62,200 | 0.0% |
| Gold Resource Corp(GORO) | COM | 38068T105 | $43.3K | 101,100 | 0.0% |
| Biorestorative Therapies Inc(BRTX) | COM NEW | 090655606 | $44.0K | 24,600 | 0.0% |
| Cumberland Pharmaceuticals I(CPIX) | COM | 230770109 | $44.6K | 23,600 | 0.0% |
| City Office REIT Inc(CIO) | COM | 178587101 | $44.6K | 10,500 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $44.8K | 43,500 | 0.0% |
| Dominari Holdings Inc(DOMH) | COM NEW | 008875304 | $45.7K | 19,700 | 0.0% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $46.1K | 30,100 | 0.0% |
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $46.1K | 39,100 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $46.5K | 27,818 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $47.2K | 35,200 | 0.0% |
| Grupo Supervielle S.A.(SUPV) | SPONSORED ADR | 40054A108 | $50.0K | 22,500 | 0.0% |
| D Market Electr Svcs & Tradi(HEPS) | SPONSORED ADS | 23292B104 | $50.1K | 37,700 | 0.0% |
| Vacasa Inc | CLASS A COM | 91854V107 | $50.3K | 109,000 | 0.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $50.3K | 64,437 | 0.0% |
| Inotiv Inc(NOTV) | COM | 45783Q100 | $50.5K | 16,400 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $50.9K | 76,800 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $52.0K | 55,200 | 0.0% |
| Growgeneration Corp(GRWG) | COM | 39986L109 | $53.7K | 18,400 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $54.4K | 13,800 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $54.7K | 62,900 | 0.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $55.7K | 11,600 | 0.0% |
| Alaunos Therapeutics Inc | COM | 98973P101 | $56.8K | 431,192 | 0.0% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $57.0K | 41,000 | 0.0% |
| Omniab Inc(OABI) | COM | 68218J103 | $57.4K | 11,050 | 0.0% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $57.7K | 19,900 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $58.4K | 10,200 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $58.5K | 25,100 | 0.0% |